Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent.


Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
23 Nov 2020
Historique:
received: 02 04 2020
accepted: 19 11 2020
entrez: 24 11 2020
pubmed: 25 11 2020
medline: 11 5 2021
Statut: epublish

Résumé

The resistance rate of Helicobacter pylori to clarithromycin (CAM) is high among infected children in Japan. Therefore, a new method for detecting CAM-resistant H. pylori using a minimally invasive technique is strongly desired. We aimed to investigate the clinical usefulness of our newly developed nested polymerase chain reaction-quenching probe (Nested PCR-QP) method using stool specimens. We first evaluated our method using a residual solution of the H. pylori stool antigen test for adolescents. Then, we evaluated our method using culture testing for adults. Among 57 middle school students with H. pylori, the Nested PCR-QP test results of 53 (90.3%) were able to be analyzed. A total of 28 students had CAM resistance mutations. We found a genetic mutation in 28 students and no mutation in 23 students, and these results were consistent with those of PCR-direct sequencing. In the 23 adults who were diagnosed with H. pylori infection using the rapid urease test and culture testing, we were able to use Nested PCR-QP for analyzing 21 adults who tested positive in the stool H. pylori antigen test. The results obtained for all 21 adults were consistent with those obtained via the drug susceptibility test. Our novel method could be useful for non-invasively detecting CAM resistance mutations in H. pylori. This may help select a drug to reduce eradication failure rates against H. pylori. Trial registration This study was registered with the University Hospital Medical Information Network Clinical Trials Registry (no. UMIN000030632, https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034977 ) on 29 December 2017.

Sections du résumé

BACKGROUND BACKGROUND
The resistance rate of Helicobacter pylori to clarithromycin (CAM) is high among infected children in Japan. Therefore, a new method for detecting CAM-resistant H. pylori using a minimally invasive technique is strongly desired. We aimed to investigate the clinical usefulness of our newly developed nested polymerase chain reaction-quenching probe (Nested PCR-QP) method using stool specimens.
METHODS METHODS
We first evaluated our method using a residual solution of the H. pylori stool antigen test for adolescents. Then, we evaluated our method using culture testing for adults.
RESULTS RESULTS
Among 57 middle school students with H. pylori, the Nested PCR-QP test results of 53 (90.3%) were able to be analyzed. A total of 28 students had CAM resistance mutations. We found a genetic mutation in 28 students and no mutation in 23 students, and these results were consistent with those of PCR-direct sequencing. In the 23 adults who were diagnosed with H. pylori infection using the rapid urease test and culture testing, we were able to use Nested PCR-QP for analyzing 21 adults who tested positive in the stool H. pylori antigen test. The results obtained for all 21 adults were consistent with those obtained via the drug susceptibility test.
CONCLUSIONS CONCLUSIONS
Our novel method could be useful for non-invasively detecting CAM resistance mutations in H. pylori. This may help select a drug to reduce eradication failure rates against H. pylori. Trial registration This study was registered with the University Hospital Medical Information Network Clinical Trials Registry (no. UMIN000030632, https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034977 ) on 29 December 2017.

Identifiants

pubmed: 33228552
doi: 10.1186/s12876-020-01549-9
pii: 10.1186/s12876-020-01549-9
pmc: PMC7682763
doi:

Substances chimiques

Anti-Bacterial Agents 0
Indicators and Reagents 0
Clarithromycin H1250JIK0A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

397

Références

J Gastroenterol. 2019 Aug;54(8):699-707
pubmed: 30770975
JAMA. 2004 Jan 14;291(2):187-94
pubmed: 14722144
Helicobacter. 2017 Oct;22(5):
pubmed: 28771894
Helicobacter. 2007 Apr;12(2):157-63
pubmed: 17309753
J Gastroenterol. 2020 Oct;55(10):969-976
pubmed: 32666199
Pediatr Int. 2010 Apr;52(2):187-90
pubmed: 19563459
Toxins (Basel). 2018 Apr 19;10(4):
pubmed: 29671784
Cell Host Microbe. 2014 Mar 12;15(3):306-16
pubmed: 24629337
Gastroenterol Clin North Am. 2015 Sep;44(3):639-48
pubmed: 26314673
J Gastroenterol. 2007 Jan;42 Suppl 17:21-7
pubmed: 17238021
J Antimicrob Chemother. 1997 Nov;40(5):713-6
pubmed: 9421321
Gut. 2016 Sep;65(9):1439-46
pubmed: 26935876
N Engl J Med. 2001 Sep 13;345(11):784-9
pubmed: 11556297
Gastroenterol Clin North Am. 2015 Sep;44(3):667-76
pubmed: 26314676
World J Gastroenterol. 2016 Nov 7;22(41):9214-9221
pubmed: 27895408
J Clin Microbiol. 2002 Feb;40(2):649-53
pubmed: 11825987
BMJ. 2013 Aug 07;347:f4587
pubmed: 23926315
Can J Gastroenterol. 1999 Sep;13(7):607-10
pubmed: 10519960
Jpn J Clin Oncol. 2017 Nov 1;47(11):1097-1102
pubmed: 28977484
Cancer Sci. 2003 Mar;94(3):235-9
pubmed: 12824915
Helicobacter. 2008 Aug;13(4):278-81
pubmed: 18665937
J Clin Microbiol. 2017 Aug;55(8):2400-2405
pubmed: 28515219
Gastric Cancer. 2019 May;22(3):435-445
pubmed: 30206731
Nucleic Acids Res. 2001 Mar 15;29(6):E34
pubmed: 11239011
Pediatr Int. 2017 Jan;59(1):57-61
pubmed: 27223686
J Gastroenterol. 2018 Mar;53(3):354-361
pubmed: 29138921
Digestion. 2018;98(2):75-80
pubmed: 29698942
J Gastroenterol. 2011 Dec;46(12):1353-60
pubmed: 21853260
J Med Microbiol. 2007 Sep;56(Pt 9):1174-1180
pubmed: 17761479
J Clin Microbiol. 2007 Jun;45(6):1718-22
pubmed: 17392440
Gut. 2015 Sep;64(9):1353-67
pubmed: 26187502
J Gastroenterol. 2004 Sep;39(9):838-43
pubmed: 15565402
Pediatr Int. 2020 Jul 13;:
pubmed: 32657507
Helicobacter. 2014 Jun;19(3):214-20
pubmed: 24758533
Gastric Cancer. 2017 Mar;20(Suppl 1):16-19
pubmed: 28093653
J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):991-1003
pubmed: 28541262
Gastroenterology. 2002 Jul;123(1):92-105
pubmed: 12105837
J Infect Chemother. 2018 Jul;24(7):538-543
pubmed: 29605555

Auteurs

Toshihiko Kakiuchi (T)

Department of Pediatrics, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga-shi, Saga, 849-8501, Japan. kakiucht@cc.saga-u.ac.jp.

Kazutoshi Hashiguchi (K)

Division of Gastroenterology, Department of Internal Medicine, Imamura Hospital, Tosu, Japan.

Ichiro Imamura (I)

Division of Gastroenterology, Department of Internal Medicine, Imamura Hospital, Tosu, Japan.

Aiko Nakayama (A)

Department of Pediatrics, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga-shi, Saga, 849-8501, Japan.

Ayako Takamori (A)

Division of Clinical Research Center, Saga University Hospital, Saga, Japan.

Masumi Okuda (M)

Department of Pediatrics, Hyogo College of Medicine, Nishinomiya, Japan.

Muneaki Matsuo (M)

Department of Pediatrics, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga-shi, Saga, 849-8501, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH